Skip to main content
Cancers logoLink to Cancers
. 2020 Jan 10;12(1):178. doi: 10.3390/cancers12010178

Erratum: Passardi, A. et al. Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. Cancers 2019, 11, 663

Alessandro Passardi 1, Emanuela Scarpi 2,*, Elisa Neri 3, Elisabetta Parisi 3, Giulia Ghigi 3, Giorgio Ercolani 4,5, Andrea Gardini 4, Giuliano La Barba 4, Flavia Pagan 2, Andrea Casadei-Gardini 1, Martina Valgiusti 1, Fabio Ferroni 6, Giovanni Luca Frassineti 1, Antonino Romeo 3
PMCID: PMC7016811  PMID: 31936817

The authors wish to make the following corrections to this paper [1]:

The institute name in affiliations 2, 3 and 6 in [1] “IRST-IRCCS” should be written in full, and changed to “Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS”.

The authors would like to apologize for any inconvenience caused to the readers by these changes.

Reference

  • 1.Passardi A., Scarpi E., Neri E., Parisi E., Ghigi G., Ercolani G., Gardini A., La Barba G., Pagan F., Casadei-Gardini A., et al. Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. Cancers. 2019;11:663. doi: 10.3390/cancers11050663. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancers are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES